Time From Diagnosis to Chemotherapy Initiation Is Not Associated with Survival Among Patients Receiving Neoadjuvant Therapy for Pancreatic Adenocarcinoma
Publication/Presentation Date
11-2021
Volume
233
Issue
5
First Page
124
Last Page
124
Published In/Presented At
Hue, Jonathan J. MD; Sugumar, Kavin MD; Rothermel, Luke MD; Ammori, John B. MD, FACS; Hardacre, Jeffrey M. MD, FACS; Winter, Jordan M. MD, FACS; Ocuin, Lee M. MD, FACS. Time From Diagnosis to Chemotherapy Initiation Is Not Associated with Survival Among Patients Receiving Neoadjuvant Therapy for Pancreatic Adenocarcinoma. Journal of the American College of Surgeons 233(5):p e124, November 2021. | DOI: 10.1016/j.jamcollsurg.2021.08.333
Disciplines
Medicine and Health Sciences
Department(s)
Department of Surgery, Lehigh Valley Topper Cancer Institute
Document Type
Article
COinS
